Odanacatib: Osteoporosis Drug Reduces Fracture Risk In Trial
The company said it expects to report final results from the study next year. Wall Street analysts, on average, have forecast
odanacatib osteoporosis drug reduce fracture risk trial company say expect report final result study year wall street analyst average forecast